Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2,2'-((6S,9S,12R,17R,20S,23S,25aS,31S,34S,37S,40S,43R,46S,48aS,53R)-31,34,40-tris(2-amino-2-oxoethyl)-53-(2-aminoacetamido)-17-carbamoyl-46-(3-guanidinopropyl)-20-(4-hydroxybenzyl)-9-(hydroxymethyl)-37-(2-(methylthio)ethyl)-5,8,11,19,22,25,30,33,36,39,42,45,48,54-tetradecaoxotetratetracontahydro-1H,5H-12,43-(epiminopropanodithiomethano)dipyrrolo[2,1-h1:2',1'-m][1,2]dithia[5,8,11,14,17,20,23,26,29,32,35,38,41]tridecaazacyclotetratetracontine-6,23-diyl)diacetic acid
ID: ALA5209526
PubChem CID: 168296899
Max Phase: Preclinical
Molecular Formula: C67H99N23O25S5
Molecular Weight: 1787.00
Associated Items: